Molecular characterization and phylogenetic analysis of a dengue virus serotype 3 isolated from a Chinese traveler returned from Laos

Abstract Background Dengue virus (DENV) infection caused by international visitors has become a public health concern in China. Although sporadic imported cases of DENV have been documented in Yunnan, China since 2000, a complete genome sequence of dengue virus serotype 3 (DENV-3) imported from Laos is still not available. Here, we report the first complete genome sequence and genomic characterization of a DENV-3 strain (YNPE3) isolated from a patient returned from Laos. Methods Viral isolation from the patient’s serum was performed using mosquitoes C6/36 cells. Reverse transcriptase polymerase chain reaction (RT-PCR) was used for identification and serotyping of the virus. The complete sequence was determined by Sanger dideoxy sequencing. Homology analysis was implemented by NCBI-BLAST. Multiple sequence alignment was performed using MegAlign module of the Lasergene 7 software package DNASTAR. MFOLD software was used to predict the RNA secondary structure of 5′ untranslated region (UTR) and 3′ UTR. Phylogenetic analysis, which was based on envelope gene and complete coding sequence, was performed by Maximum-Likelihood method. Results RT-PCR analysis confirmed that the virus belonged to dengue virus serotype 3, which was named YNPE3 strain. The full-length genome of the YNPE3 strain was 10,627 nucleotides (nts) with an open reading frame (ORF) encoding 3390 amino acids. Strain YNPE3 shared 98.6–98.8% nucleotide identity with the closely related strains isolated in India (JQ922556, KU216209, KU216208). We observed the deletion of about 40 nts in the 5′ UTR and 3′ UTR of strain YNPE3, and 11 nts (ACGCAGGAAGT) insertion that was present in the 3′ UTR of YNPE3. Compared with prototype strain H87, abundant amino acid substitutions in the YNPE3 strain were observed. Phylogenetic analysis revealed that the YNPE3 strain belonged to genotype III of DENV-3, and that it might be closely related with genotype III strains isolated in Laos and India. Conclusions This is the first report of the complete genome sequence and molecular characterization of a DENV-3 isolate imported from Laos. The presented results can further promote disease surveillance, and epidemiological and evolutionary studies of the DENV-3 in Yunnan province of China

Full-length genome and molecular characterization of dengue virus serotype 2 isolated from an imported patient from Myanmar

Abstract Background Dengue is the most common mosquito-borne infection worldwide and a serious threat to global public health. Sporadic dengue virus serotype 2 (DENV-2) imported cases from Myanmar have been documented almost every year in Yunnan Province of China since 2005. However, the complete genome sequences of DENV-2 isolates imported from Myanmar are not available. Methods The full-length genome of the DENV-2 strain (YNPE2), isolated from an imported case from Myanmar in 2013, was identified by the next-generation sequencing. The extreme ends of the viral genome were validated by 5′/3′ RACE and Sanger sequencing. Furthermore, phylogenetic, recombination and selection pressure analyses were conducted for the molecular characterization of YNPE2 strain. Results Whole-genome sequencing revealed that the full-length sequence of YNPE2 strain was 10,724 bases, with an open reading frame encoding for 3391 amino acids. The YNPE2 strain had 99.0% nucleotide identity and 99.8% amino acid identity with two closely related strains, ThD2_0078_01 strain (DQ181797) and DENV-2/TH/BID-V2157/200 strain (FJ639832). The phylogenetic analysis suggested that the YNPE2 strain belonged to Asian I genotype and was likely derived from Thailand strain (DQ181797). Moreover, selection pressure analysis revealed two amino acid sites of the NS4B and NS5 proteins, with important evidence of positive selection. Conclusion This study revealed the first complete genome sequence and molecular characterization of a DENV-2 strain (YNPE2) isolated from an imported case from Myanmar, thus providing a valuable reference genome source for future surveillance, epidemiology and vaccine development of DENV-2 virus in Yunnan, China

Epitope-Based Vaccine Target Screening against Highly Pathogenic MERS-CoV: An In Silico Approach Applied to Emerging Infectious Diseases.

Middle East respiratory syndrome coronavirus (MERS-CoV) with pandemic potential is a major worldwide threat to public health. However, vaccine development for this pathogen lags behind as immunity associated with protection is currently largely unknown. In this study, an immunoinformatics-driven genome-wide screening strategy of vaccine targets was performed to thoroughly screen the vital and effective dominant immunogens against MERS-CoV. Conservancy and population coverage analysis of the epitopes were done by the Immune Epitope Database. The results showed that the nucleocapsid (N) protein of MERS-CoV might be a better protective immunogen with high conservancy and potential eliciting both neutralizing antibodies and T-cell responses compared with spike (S) protein. Further, the B-cell, helper T-cell and cytotoxic T lymphocyte (CTL) epitopes were screened and mapped to the N protein. A total of 15 linear and 10 conformal B-cell epitopes that may induce protective neutralizing antibodies were obtained. Additionally, a total of 71 peptides with 9-mer core sequence were identified as helper T-cell epitopes, and 34 peptides were identified as CTL epitopes. Based on the maximum HLA binding alleles, top 10 helper T-cell epitopes and CTL epitopes that may elicit protective cellular immune responses against MERS-CoV were selected as MERS vaccine candidates. Population coverage analysis showed that the putative helper T-cell epitopes and CTL epitopes could cover the vast majority of the population in 15 geographic regions considered where vaccine would be employed. The B- and T-cell stimulation potentials of the screened epitopes is to be further validated for their efficient use as vaccines against MERS-CoV. Collectively, this study provides novel vaccine target candidates and may prompt further development of vaccines against MERS-CoV and other emerging infectious diseases

Inferring Protective CD8⁺ T-Cell Epitopes for NS5 Protein of Four Serotypes of Dengue Virus Chinese Isolates Based on HLA-A, -B and -C Allelic Distribution: Implications for Epitope-Based Universal Vaccine Design

<div><p>Dengue is one of the most globally serious vector-borne infectious diseases in tropical and subtropical areas for which there are currently no effective vaccines. The most highly conserved flavivirus protein, NS5, is an indispensable target of CD8⁺ T-cells, making it an ideal vaccine design target. Using the Immune Epitope Database (IEDB), CD8⁺ T-cell epitopes of the dengue virus (DENV) NS5 protein were predicted by genotypic frequency of the HLA-A,-B, and-C alleles in Chinese population. Antigenicity scores of all predicted epitopes were analyzed using VaxiJen v2.0. The IEDB analysis revealed that 116 antigenic epitopes for HLA-A (21),-B (53), and-C (42) had high affinity for HLA molecules. Of them, 14 had 90.97–99.35% conversancy among the four serotypes. Moreover, five candidate epitopes, including ²⁰⁰NS5²¹⁰ (94.84%, A*11:01), ⁵¹⁵NS5⁵²⁵ (98.71%, A*24:02), ²²⁵NS5²³² (99.35%, A*33:03), ⁵¹⁶NS5⁵²³ (98.71%, A*33:03), and ²⁸⁴NS5²⁹¹ (98.06%, A*33:03), were presented by HLA-A. Four candidate epitopes, including ²³⁴NS5²⁴¹ (96.77%, B*13:01), ⁹²NS5⁹⁹ (98.06%, B*15:01, B*15:02, and B*46:01), ²⁶²NS5²⁶⁹ (92.90%, B*38:02), and ⁵³⁸NS5⁵⁴⁷ (90.97%, B*51:01), were presented by HLA-B. Another 9 candidate epitopes, including ⁵¹⁴NS5⁵²² (98.71%, C*01:02), ⁵¹⁴NS5⁵²⁴ (98.71%, C*01:02 and C*14:02), ⁹²NS5⁹⁹ (98.06%, C*03:02 and C*15:02), ³⁶²NS5³⁶⁹ (44.84%, C*03:04 and C*08:01), ²²⁵NS5²³² (99.35%, C*04:01), ²³⁴NS5²⁴¹(96.77%, C*04:01), ³⁶¹NS5³⁶⁹ (94.84%, C*04:01), ⁵¹⁵NS5⁵²² (98.71%, C*14:02), ⁵¹⁵NS5⁵²⁴ (98.71%, C*14:02), were presented by HLA-C. Further data showed that the four-epitope combination of ⁹²NS5⁹⁹ (B*15:01, B*15:02, B*46:01, C*03:02 and C*15:02), ²⁰⁰NS5²¹⁰ (A*11:01), ³⁶²NS5³⁶⁹ (C*03:04, C*08:01), and ⁵¹⁴NS5⁵²⁴ (C*01:02, C*14:02) could vaccinate >90% of individuals in China. Further <i>in vivo</i> study of our inferred novel epitopes will be needed for a T-cell epitope-based universal vaccine development that may prevent all four China-endemic DENV serotypes.</p></div

Frequency of HLA class I alleles (>3%) in Chinese population.

<p>Frequency of HLA class I alleles (>3%) in Chinese population.</p

HLA-A restricted epitopes of the NS5 protein and their binding affinity, antigenicity and conservation (in percentages) in different serotypes.

<p>^aThe epitopes location in NS5 protein are from accession number: KC131142.1.</p><p>Bold and italic- indicates the percentage of epitope that is 100% conserved in more than 90% of the sequences analysed in four serotypes.</p><p>HLA-A restricted epitopes of the NS5 protein and their binding affinity, antigenicity and conservation (in percentages) in different serotypes.</p

Population coverage rate (%) for the highly conserved epitopes that could be as multiple epitope-based universal vaccine candidates.

<p>^aThe epitopes location in NS5 protein are from accession number: KC131142.1.</p><p>Population coverage rate (%) for the highly conserved epitopes that could be as multiple epitope-based universal vaccine candidates.</p

Additional file 3: of Molecular characterization and phylogenetic analysis of a dengue virus serotype 3 isolated from a Chinese traveler returned from Laos

Table S3. Sequence information used in E gene phylogenetic tree construction. (DOC 88 kb

Additional file 2: of Molecular characterization and phylogenetic analysis of a dengue virus serotype 3 isolated from a Chinese traveler returned from Laos

Table S2. Primers used for the complete genome amplification. (DOC 38 kb